Insulin-like Growth Factor-1 Receptor Inhibitors [MoA] - N0000193927

Name: Table of NDC products with insulin-like growth factor-1 receptor inhibitors
Creator: U.S. Food & Drug Administration
License: https://creativecommons.org/licenses/by-nc-sa/4.0/

Pharmacologic Class Information

Pharmacologic Code	N0000193927
Pharmacologic Name	Insulin-like Growth Factor-1 Receptor Inhibitors
Pharmacologic Uses	insulin-like growth factor-1 receptor inhibitor
Pharmacologic Concept	Mechanisms of Action - [MoA]
Pharmacologic Concept Description	This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept.

NDC Products with Insulin-like Growth Factor-1 Receptor Inhibitors

The table contains 1 products whose active ingredient are classified under the same pharmacologic class Insulin-like Growth Factor-1 Receptor Inhibitors [MoA].

	NDC	Proprietary Name	Non-Proprietary Name	Dosage Form	Route Name	Company Name	Status
	75987-130	Tepezza	Non-Proprietary Name: Teprotumumab	Injection, Powder, Lyophilized, For Solution	Intravenous	Horizon Therapeutics Usa, Inc.	ACTIVE